Wire Stories
Dr. Reddy’s Laboratories enters into a Licensing Agreement with Gilead Sciences for Remdesivir
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to...